Fluidigm Corp (FLDM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Fluidigm Corp (FLDM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7326
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instruments, integrated fluidic circuits and assays and reagents to clinical research laboratories; academic institutions; biopharmaceutical, biotechnology, and agricultural biotechnology companies; and contract research organizations worldwide. Fluidigm manufactures its products through multi-layer soft lithography technology and CyTOF technology, among others. The company distributes its systems through direct sales force and support organizations across North America, Europe and Asia-Pacific; and also through a network of distributors across Europe, Latin America, the Middle East and Asia-Pacific. Fluidigm is headquartered in South San Francisco, California, the US.

Fluidigm Corp (FLDM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Fluidigm Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Fluidigm Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Fluidigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Fluidigm Corp, Medical Equipment, Deal Details 11
Venture Financing 11
Fluidigm Raises USD76.80 Million in Venture Financing 11
Partnerships 12
Fluidigm Enters into Licensing Agreement with Baylor Genetics Labs 12
Fluidigm Enters into Co-Marketing Agreement with Visiopharm 13
Fluidigm and Ascendas Genomics Enter into Partnership 14
Fluidigm Enters into Distribution Agreement with GenomOncology 15
OpGen Enters into Co-Development Agreement with Fluidigm 16
Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 17
Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 19
Equity Offering 20
Fluidigm Raises USD30 Million in Public Offering of Shares 20
Fluidigm Completes Public Offering Of Common Stock For US$60 Million 21
Debt Offering 23
Fluidigm Completes Public Offering Of Notes Due 2034 For US$201.3 Million 23
Acquisition 25
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million 25
Fluidigm Corp – Key Competitors 27
Fluidigm Corp – Key Employees 28
Fluidigm Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 02, 2018: Fluidigm announces second quarter 2018 financial results 30
May 03, 2018: Fluidigm Announces First Quarter Financial Results and Operational Progress 32
Feb 08, 2018: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress 34
Nov 02, 2017: Fluidigm Announces Third Quarter Financial Results and Operational Progress 36
Aug 03, 2017: Fluidigm Announces Second Quarter Financial Results and Operational Progress 38
May 04, 2017: Fluidigm Announces First Quarter Financial Results 40
Feb 08, 2017: Fluidigm Announces Q4 And Full Year 2016 Financial Results 43
Jan 09, 2017: Fluidigm Announces Preliminary Revenue For The Fourth Quarter And Full Year 45
Corporate Communications 46
Jun 26, 2018: Fluidigm Appoints David King As Vice President, Research and Development, Genomics 46
Apr 23, 2018: Fluidigm Appoints Brad Kreger As Senior Vice President, Global Operations 47
Mar 27, 2017: Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors 48
Product News 49
Aug 09, 2018: Fluidigm to host 2nd annual imaging mass cytometry user group meeting 49
Apr 13, 2018: Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research 50
Oct 24, 2017: Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues 51
Oct 18, 2017: Fluidigm to Unveil High-Parameter Tissue Imaging System 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Fluidigm Corp, Medical Equipment, Key Facts, 2017 2
Fluidigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Fluidigm Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Fluidigm Corp, Deals By Market, 2012 to YTD 2018 9
Fluidigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Fluidigm Raises USD76.80 Million in Venture Financing 11
Fluidigm Enters into Licensing Agreement with Baylor Genetics Labs 12
Fluidigm Enters into Co-Marketing Agreement with Visiopharm 13
Fluidigm and Ascendas Genomics Enter into Partnership 14
Fluidigm Enters into Distribution Agreement with GenomOncology 15
OpGen Enters into Co-Development Agreement with Fluidigm 16
Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 17
Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 19
Fluidigm Raises USD30 Million in Public Offering of Shares 20
Fluidigm Completes Public Offering Of Common Stock For US$60 Million 21
Fluidigm Completes Public Offering Of Notes Due 2034 For US$201.3 Million 23
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million 25
Fluidigm Corp, Key Competitors 27
Fluidigm Corp, Key Employees 28
Fluidigm Corp, Subsidiaries 29

List of Figures
Fluidigm Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Fluidigm Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Fluidigm Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Fluidigm Corp (FLDM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Capture Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Capture Vascular Inc (Capture Vascular) is a medical device development company that develops and commercializes mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and …
  • Ventana Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pa …
  • Costco Wholesale Corporation:企業の戦略・SWOT・財務分析
    Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Assam Company India Ltd (ASSAMCO):企業の財務・戦略的SWOT分析
    Assam Company India Ltd (ASSAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • WS Atkins Plc:戦略・SWOT・企業財務分析
    WS Atkins Plc - Strategy, SWOT and Corporate Finance Report Summary WS Atkins Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kina Petroleum Ltd (KPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Kina Petroleum Limited (KPL) is an upstream oil and gas company that focuses on exploration, development and production activities. It has operations in Papua New Guinea (PNG) and Australia. The company focuses on participating in highly prospective oil and gas acreage positions near to prov …
  • Hitachi Ltd (6501):電力:M&Aディール及び事業提携情報
    Summary Hitachi Ltd (Hitachi) is a multinational company with operations in sectors such as engineering and electronics, nuclear, transportation and industrial systems. It manufactures and sells information and telecommunication systems, power systems, social infrastructure and industrial systems, c …
  • Brain Tunnelgenix Technologies Corp:医療機器:M&Aディール及び事業提携情報
    Summary Brain Tunnelgenix Technologies Corp (BTT Corp) is a medtech company that develops, manufactures and markets solutions based on the brain thermal tunnel. The company offers various research system, windows based application which provides the sensor data acquisition, data ingestion up to the …
  • Cofidis Participations S.A.
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Stena AB:企業の戦略的SWOT分析
    Stena AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Chronix Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Chronix Biomedical Inc (Chronix Biomedical) is a molecular diagnostic company that develops blood tests for monitoring minimal residual disease in cancer patients. The company offers tests such as second opinion tests and delta dot tests. Its second opinion tests include supplementary blood …
  • Edmond De Rothschild (Suisse) S.A.:企業の戦略・SWOT・財務分析
    Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Jackson Electric Membership Corporation:発電所・企業SWOT分析
    Jackson Electric Membership Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • PIQUR Therapeutics AG-製薬・医療分野:企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Vocalink Limited:企業の戦略・SWOT・財務分析
    Vocalink Limited - Strategy, SWOT and Corporate Finance Report Summary Vocalink Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • KPMG International:企業の戦略・SWOT・財務分析
    KPMG International - Strategy, SWOT and Corporate Finance Report Summary KPMG International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Daihachi Chemical Industry Co Ltd:企業の戦略的SWOT分析
    Daihachi Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Iberia Lineas Aereas De Espana, Sa
    Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report Summary Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • TH Heavy Engineering Bhd (THHEAVY):企業の財務・戦略的SWOT分析
    TH Heavy Engineering Bhd (THHEAVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PZ Cormay SA (CRM):医療機器:M&Aディール及び事業提携情報
    Summary PZ Cormay SA (Cormay) is a medical device company that produces and wholesale diagnostic reagents and laboratory equipment. The company provides products such as reagents, analyzers, coagulation, electrophoresis, urinalysis, rapid tests, assay sheets, and blood control instruments and equipm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆